skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
Dextroamphetamine-Amphetamine (Code C26643)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Dextroamphetamine-Amphetamine

Definition: A combination of two synthetic agents with central nervous system stimulant activity. Both agents are non-catecholamine, sympathomimetic agents that elevate blood pressure and cause bronchodilation. These agents are commonly abused psychostimulant drugs that induce psychologic dependence manifested by elevated mood, increased wakefulness, concentration, physical performance and a feeling of well-being. Tolerance to various effects develops unequally, so that tachycardia and enhanced alertness diminish while psychotoxic effects (hallucinations and delusions) may occur. (NCI04)

NCI-GLOSS Definition: A combination of drugs used as a treatment for attention deficit hyperactivity disorder (ADHD) and narcolepsy (a sleep disorder). It is a type of stimulant.

Label: Dextroamphetamine-Amphetamine

NCI Thesaurus Code: C26643 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C0795571  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
Adderall XR

External Source Codes: 
PDQ Closed Trial Search ID 304345
PDQ Open Trial Search ID 304345 (check for NCI PDQ open clinical trial info)
UMLS CUI C0795571

Other Properties:
     Name Value (qualifiers indented underneath)
Accepted_Therapeutic_Use_For Attention deficit hyperactive disorder; Narcolepsy
code C26643
Legacy_Concept_Name Dextroamphetamine-Amphetamine
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom